
Excited to present the latest validation data (386 consecutive patients) for our novel pressure-regulated deployment strategy in Sapien 3 BE-TAVs. #ESCCongress later today - Station 4 15:15!
Spoiler alert: the results are excellent ✅
@escardio @thecsanz
…c2023-abstract.medicalcongress.online/mediatheque/me…
English













